Startups

Shanghai Active Technology

Shanghai, China

上海主动科技有限公司, invasive BCI developer spun out of Lingang Laboratory, associated with the Tianshu 1024-channel system. Investor confirms Jia Jing CTO; legal details and CEO rely partly on secondary registry/reporting. Official domain and company portrait remain unverified.

Team

Jia JingCTO

Investments

No investment rounds on record yet.

team@apexlogos.ai2 days ago
RELATED
team@apexlogos.ai2 days ago
BCI research snapshot, reviewed 2026-10-06. Company identity: ShanghaiActiveTechnology. This is the pre-import evidence dossier; historical statements about database absence or review are archival. Unverified claims remain research leads, not validated facts. Part 1/1 # Active Technology / 主动科技 Research accessed **2026-10-06**. Decision: **real Shanghai BCI company, absent from ADEX; hold official website/logo and definitive team import pending verification**. Suggested ID `ActiveTechnology` with Chinese legal name mandatory for disambiguation. ## Identity and pasted-list audit The target is **上海主动科技有限公司**, approximately Shanghai Active Technology Co., Ltd., not the unrelated ElectroActive Technologies. A [Chinese registry-data aggregator](https://www.shuididp.cn/yp-d4fb85ed21d1ab63f7e4b0591c5c0c01.html) records incorporation **2026-02-02**, unified social credit code **91310115MAK6P5JMXW**, legal representative **贾婧 / Jia Jing**, and active status. It lists a registered address at **528 Ruiqing Road, Building 20B, floor 6, Pudong, Shanghai**. This is secondary registry reproduction, not a directly inspected government filing; other published addresses may be earlier registration/operating locations. The company specializes in **invasive BCI**, spun out of Lingang Laboratory, with a reported **Tianshu / 天枢 1,024-channel** system. [Contemporaneous company-report coverage](https://www.parkworld.net/Post/8def2e240a02e95) describes planned clinical trials; do not turn prospective trials, type testing or claimed channel count into regulatory clearance or established commercial deployment. | Pasted claim | Audit | |---|---| | Company in Shanghai | Supported by registry reproduction, industry reports and independent investor event account. | | Active | Supported, but early development stage; not established commercial medical-product clearance. | | RMB330M raised | Supported as **one announced angel round, August 3, 2026**, not an independently audited lifetime total. | | CEO blank | Wu Guojia is reported CEO; primary current appointment source still needed. | ## Existing ADEX Read-only `Org` id/name/description/json(extra) review in `data/db.sqlite3`: no exact Active Technology/上海主动科技/主动科技 match. `ElectroActiveTechnologies` is an unrelated company and must not be matched. No DB writes made. ## Official domain and company picture **Authoritative company URL and direct logo/profile-picture URL unavailable.** A directory points to `https://www.active-tech.cn`, which did not resolve. Search indexed `https://www.zihuo.online/` with a self-described Active Technology company page, while ordinary HTTPS retrieval failed hostname-certificate validation and HTTP retrieval timed out. Its purported canonical/email domain `aitbci.com` did not resolve. These inconsistent domains prevent treating its logo or team images as authenticated official assets. Do not invent an official domain or borrow another company's logo. Review [independent investor evidence](https://en.jifengventures.com/pages/186/) and [funding announcement coverage](https://eu.36kr.com/zh/newsflashes/3923172519374216) instead. ## Public team and image evidence The strongest first-party evidence is **JF Capital's own event account**, describing an April 9–10, 2026 investor meeting and explicitly naming Jia Jing as Active Technology CTO. June 11 in the image filename is an upload/screenshot date, not the event date. [Investor account](https://en.jifengventures.com/pages/186/). | Person | Role and confidence | Profile / role source | Direct pfp / image status | |---|---|---|---| | 贾婧 / Jia Jing | CTO confirmed by investor; chairman/legal representative in secondary registry | [First-party investor profile in event text](https://en.jifengventures.com/pages/186/), [registry reproduction](https://www.shuididp.cn/yp-d4fb85ed21d1ab63f7e4b0591c5c0c01.html) | Individual headshot **unavailable**. [Direct panel photograph](https://en.jifengventures.com/media/pages/2026-06/be9be222-655c-11f1-8a68-9fcfb05ace57.png): caption identifies Jia as third person from left; **group photo, not ready pfp**. | | 吴国佳 / Wu Guojia | CEO, company-report coverage; current primary appointment pending | [Reported CEO interview/background](https://www.parkworld.net/Post/8def2e240a02e95) | Unavailable after company-domain, former employer and leadership/photo searches. | | 赵斌 / Zhao Bin | Technical leadership reported; director/financial officer in registry reproduction | [Company-report coverage](https://www.parkworld.net/Post/8def2e240a02e95), [registry reproduction](https://www.shuididp.cn/yp-d4fb85ed21d1ab63f7e4b0591c5c0c01.html) | Unavailable; no authenticated individual image located. | | 伊国良 / Yi Guoliang | Technical leadership reported; specific corporate title unverified | [Company-report coverage](https://www.parkworld.net/Post/8def2e240a02e95) | Unavailable; no authenticated individual image located. | | 于翔 / Yu Xiang | Director, secondary registry reproduction only | [Registry reproduction](https://www.shuididp.cn/yp-d4fb85ed21d1ab63f7e4b0591c5c0c01.html) | Unavailable; identity requires review before matching another Yu Xiang. | Names are not proof that every listed person is a cofounder. A first-party Lingang Laboratory site search and investor portfolio searches did not establish a complete photographed current roster. The dubious company-domain page's more detailed roles are not imported as authoritative facts. ## Funding | Announcement date | Amount / round | Lead | Named participants | Evidence | |---|---|---|---|---| | **2026-08-03** | **CNY 330,000,000 / RMB 3.3亿元**, angel equity financing | **中科创星 / CAS Star** | **联想之星 / Lenovo Star; 九合创投 / Unity Ventures; 道彤投资; 英诺天使基金; 华大松禾生科基金; 济峰资本 / JF Capital; 嘉道资本** | [36Kr contemporaneous announcement](https://eu.36kr.com/zh/newsflashes/3923172519374216) | Preserve Chinese names for exact investor/fund matching; **九合创投 is not Joy Capital**. Legal investment vehicles may differ from manager brands. Registered capital of CNY1.55M is not the round amount. No other priced round, acquisition, debt or quantified grant established. Searches of lead/investor official sites did not locate a fully accessible original financing release; mark this round as company-announcement coverage pending original-source review. ## Review decision Validate and retain the company candidate, Shanghai, Chinese legal identity and announced round with its source. Hold domain/logo/current individual pictures; keep CEO and technical roles provisional except the investor-confirmed CTO. Regulatory/product-stage claims need trial or regulator evidence before enrichment. Do not reject the company merely because its official website could not be authenticated.